Alkem Laboratories News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Alkem Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 3
Author: Motilal Oswal

Keep track of all breaking news and updates on Alkem Laboratories from all sources in a single place.

Load latest

Alkem Laboratories Ltd.

13 Nov 2025

5642.50

-0.37%

Investor Presentation

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pls find enclosed herewith the press release and analyst presentation on Q2 and H1FY26 earnings and business updates of the Company.

pdf

Alkem Laboratories Ltd.

13 Nov 2025

5642.50

-0.37%

Result

Alkem Laboratories Ltd - 539523 - Unaudited Financial Results For The Quarter And Half Year Ended …

BSE India

Pls find enclosed herewith the Unaudited Financial Results along with the LRR for the quarter and half year ended 30 September, 2025.

pdf

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	4104.68	3507.63	3549.15	17.0%	15.7%
Operating Profit Qtr	920.77	739.05	752.83	24.6%	22.3%
Net Profit Qtr	765.06	664.26	688.64	15.2%	11.1%
Earning Per Share Adjusted latest Qtr	63.99	55.56	57.60	15.2%	11.1%

* Consolidated data

Detailed Results

Alkem Laboratories Ltd.

13 Nov 2025

5642.50

-0.37%

Board Meeting

Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Dated 13 …

BSE India

Pls find enclosed the Outcome of Board Meeting dated 13.11.2025. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

13 Nov 2025

5642.50

-0.37%

Opex from CDMO/Med-tech to constrain margin expansion over the near term

Neutral: Alkem Laboratories Ltd.

Target

Motilal Oswal

ALKEM Laboratories (ALKEM) delivered better-than-expected revenue/EBITDA/PAT, with a beat of 6%/9%/13% for the quarter. The superior performance was driven by broad-based higher revenue growth and lower-than-expected R&D spend for the quarter.

Alkem Laboratories Ltd. is trading above its 200 day SMA of 5188.4

Alkem Laboratories Ltd.

10 Nov 2025

5642.50

-0.37%

Company Update

Alkem Laboratories Ltd - 539523 - EU GMP Inspection By German Health Authority At Alkem'S Manufacturing …

BSE India

Closure of EU GMP inspection by German Health Authority at Alkem''s manufacturing facility located at Baddi, India

pdf

Alkem Laboratories Ltd.

03 Nov 2025

5642.50

-0.37%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order

BSE India

Pursuant to Regulation 30 read with SEBI LODR regulations, this is to inform you that the Company has received order passed by statutory authority under the Goods and Service Tax Act, 2017. The relevant disclosure is enclosed herewith

pdf

Alkem Laboratories Ltd.

03 Nov 2025

5642.50

-0.37%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

BSE India

Press Release- Alkem Foundation and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines

pdf

Alkem Laboratories Ltd.

03 Nov 2025

5642.50

-0.37%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release - Alkem and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines.

pdf

Alkem Laboratories Ltd.

28 Oct 2025

5642.50

-0.37%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2 and H1FY26 financial results will be held on Thursday, November 13, 2025 at 04.30 p.m. Please find attached herewith the conference call details.

pdf